A.J. Rice

Stock Analyst at UBS

(2.29)
# 1139
Out of 5,218 analysts
257
Total ratings
57.45%
Success rate
18.56%
Average return
46 Stocks
Name Action Price Target Current % Upside Ratings Updated
Centene
Upgrades: Buy
79 80
59.46 34.54% 15 Dec 13, 2024
Option Care Health
Initiates Coverage On: Neutral
26
23.5 10.64% 1 Dec 5, 2024
Ensign Group
Initiates Coverage On: Buy
175
142.39 22.9% 1 Nov 21, 2024
Pediatrix Medical Gr...
Maintains: Neutral
11 17
14.06 17.35% 15 Nov 5, 2024
BrightSpring Health
Maintains: Strong Buy
20 22
18.56 18.53% 3 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
197 217
136.7 58.74% 9 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
605 555
380.91 45.7% 2 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
38
20.36 86.64% 1 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
15.41 224.46% 1 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
247 267
187.25 42.59% 13 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
66 65
27.09 139.94% 9 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
2 3
5.02 -44.22% 6 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
83 85
85.87 -1.01% 11 May 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
n/a n/a 2 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
10
8.5 11.76% 2 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
11 13
12.56 3.5% 10 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
26
19.48 33.47% 6 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
22
18.05 21.88% 6 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
250 50
n/a n/a 3 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
450 485
576.49 -15.87% 1 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
95
40.66 133.64% 13 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
311 316
314.03 0.63% 12 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 96
49.39 94.37% 6 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
62 73
98.2 -25.66% 8 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
635 575
273.6 110.16% 9 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
38
21.79 74.39% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
590 610
521.04 17.07% 12 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
308 305
232.46 31.21% 4 Nov 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
3.46 -4.62% 5 Nov 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
64 79
118.15 -33.14% 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
175 182
n/a n/a 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
350 410
303.12 35.26% 3 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18
n/a n/a 1 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 37
13.9 166.19% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
158 143
155.09 -7.8% 9 Jul 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 43
10.42 312.67% 7 Jul 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 37
31.05 19.16% 3 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
181 182
85.68 112.42% 5 Apr 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
181 170
n/a n/a 4 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 270
281.79 -4.18% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
382 425
n/a n/a 7 Apr 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
29.84 -98.09% 3 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
4
n/a n/a 1 Jan 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
207 205
n/a n/a 7 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 65
n/a n/a 5 Jul 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 44
n/a n/a 2 Jan 31, 2018